BPV Huegel has helped Sanochemia Pharmazeutika AG with its restructuring and is representing the company in court proceedings.
According to bpv Huegel, "the restructuring process without self-administration aims for reorganization and the going concern of the business."
BPV Huegel reports that: "the pharmaceutical company ([which has] more than 150 employees) is headquartered in Vienna and operates a production site in Neufeld, in the Austrian province of Burgenland. Sanochemia is active in the fields of human pharmaceuticals (the development, production, and sale of drugs for radiology, neurology, and oncology), and the production of active pharmaceutical ingredients and drug formulations, and it operates a research and development division. The group has subsidiaries in, inter alia, Germany, Switzerland, the United Kingdom, and the United States. The company’s shares are listed on the Open Market of the Frankfurt Stock Exchange and on the direct market plus of the Vienna Stock Exchange."
BPV Huegel’s team is led by Partners Bernhard Schatz and Georg Rupprecht and includes Attorney-at-Law Friedrich Rupprecht and Associate Gabriela Kohlenberger. BPV Huegel Partner Elke Napokoj has been a member of Sanochemia's Supervisory Board since 2013.